Project Grant R21GM159351
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$399K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Raleigh, NC 27606, USA
Similar Awards
This $117,074 five-year federal Project Grant award was provided by the National Science Foundation's (NSF) Mathematical and Physical Sciences program (CFDA 47.049) to Lehigh University to support research into biomaterial-guided CRISPR gene editing delivery systems. The project aims to systematically explore how the physicochemical properties of biomaterials and nanoparticles, as well as cell-material interactions, can be leveraged to enhance the spatiotemporal control, efficacy, and safety...
This five-year $385,645 Project Grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) will fund research investigating RNA-guided nucleases encoded by transposons across the three domains of life. The grantee, Columbia University, will examine an ancestral family of transposon-encoded enzymes that use guide RNAs to target and cut matching DNA sequences. These enzymes are directly related to CRISPR-Cas9 and CRISPR-Cas12 genome editing tools. The project aims to...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports research to improve the efficiency of CRISPR gene editing in human pluripotent stem cells. The goal is to develop a novel carbon nanotube array technology that can efficiently transfer nucleic acids and proteins into these cells to enhance CRISPR-based gene editing and homology-directed recombination. The $275,045 award to Advanced Gene...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $100,000 will support research to develop next-generation clustered regularly interspaced short palindromic repeat (CRISPR) systems for curing inherited diseases. Specifically, the awardee, the University of California, Berkeley, will work to circumvent in vivo delivery challenges with CRISPR-Cas9 by developing miniature RNA-guided genome editors smaller than Cas9 that can be...
This $322,020 Project Grant award from the National Science Foundation's (NSF) Division of Integrative Organismal Systems will support collaborative research at the University of California, Davis (UC Davis) to develop improved methods for CRISPR/Cas9-based gene editing in maize. The key objectives are to generate maize lines expressing high levels of Cas9 nuclease and to engineer and optimize viral vectors to efficiently deliver guide RNAs for both somatic and heritable gene editing. This...
This $387,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to understand the roles of microRNAs in animal development. The grant, awarded to The Johns Hopkins University effective May 1, 2025 through February 28, 2030, aims to systematically investigate the functions of highly conserved microRNAs during development, leveraging the C. elegans experimental system. The research...
This Project Grant award of $968,613 from the National Science Foundation Division of Molecular and Cellular Biosciences supports research into developing a novel CRISPR synthetic biology tool for investigating and reprogramming alkaloid biosynthesis regulation in Catharanthus roseus. The award was made on March 1, 2021 to Northeastern University for work to be completed by December 31, 2024 under the Biological Sciences program (CFDA 47.074). A sub-award of $100,000 was also provided to...
This $785,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will fund two key research projects at Rutgers, The State University: Project 1 will investigate the function and enzymology of the novel histone modification H3K23me3, which is induced by the nuclear RNA interference (RNAi) pathway in Caenorhabditis elegans. This research aims to elucidate the relationships between key...
This federal Project Grant award of $360,247.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) funds research to explore the diverse mechanisms of Type III CRISPR-Cas signaling in bacteria and archaea. The research aims to elucidate the function and regulation of CRISPR-associated signaling effectors, focusing on nucleases and membrane proteins, using biochemistry, structural biology, and cell biology approaches....
This $1,000,000.00 Project Grant awarded by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research to characterize the molecular mechanisms by which the bridge helix (BH) region of the CRISPR-associated (Cas) 9 and Cas12a enzymes contributes to DNA cleavage fidelity. The overarching goal is to develop error-proof variants of these genome editing tools that minimize unintended off-target DNA modifications. The award includes a sub-grant to the University...